✦ LIBER ✦

High-dose melphalan followed by autograft employing non-cryopreserved peripheral blood progenitor cells in children

✍ Scribed by N. Jones; D. Williams; V. Broadbent; K. Jestice; P. Boraks; M. Scott; S. Ager; R. Marcus

Book ID: 116167983
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 541 KB
Volume: 32
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(96)00209-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Total marrow irradiation and peripheral

Total marrow irradiation and peripheral blood progenitor cell rescue following high-dose melphalan and peripheral blood progenitor cell rescue in patients with multiple myeloma

✍ G. Somlo; S. Forman; L. Popplewell; R. Spielberger; F. Sahebi; P. Parker; T. Sch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 70 KB

High-dose mitoxantrone + melphalan (MITO

High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity

✍ Tarella, C; Zallio, F; Caracciolo, D; Cuttica, A; Corradini, P; Gavarotti, P; La 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Effective T cell regeneration following

Effective T cell regeneration following high-dose chemotherapy rescued with CD34+ cell enriched peripheral blood progenitor cells in children

✍ Heitger, A; Kern, H; Mayerl, D; Maurer, K; Nachbaur, D; Frühwirth, M; Fink, F-M; 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

Non-cryopreserved, limited number (1 or

Non-cryopreserved, limited number (1 or 2) peripheral blood progenitor cell (PBPC) collections following GCSF administration provide adequate hematologic support for high dose chemotherapy

✍ W. R. Bezwoda; R. Dansey; L. Seymour; D. Glencross 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 686 KB

## Abstract Sixty‐two patients with a variety of malignant diseases including 44 with breast cancer, seven with sarcomas, five with germ cell tumours, four with Hodgkin's disease and two with multiple myeloma received short duration, high dose chemotherapy, with non‐cryopreserved peripheral blood p

Non-cryopreserved peripheral blood proge

Non-cryopreserved peripheral blood progenitor cells collected by a single very large-volume leukapheresis: A simplified and effective procedure for support of high-dose chemotherapy

✍ Christos A. Papadimitriou; Meletios A. Dimopoulos; Vassilios Kouvelis; Evangelos 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 2 views

High-dose chemotherapy with autologous peripheral blood progenitor cell (PBPC) support has become a widely used treatment strategy. In order to simplify the procedure, a single very large-volume leukapheresis programme combined with short-term refrigerated storage of the PBPC was developed. Seventy-

Pilot Evaluation of High-Dose Carboplati

Pilot Evaluation of High-Dose Carboplatin and Paclitaxel Followed by High-Dose Melphalan Supported by Peripheral Blood Stem Cells in Previously Untreated Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

✍ Russell J. Schilder; Mark F. Brady; David Spriggs; Thomas Shea 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 56 KB